Janus Henderson Group PLC Intra Cellular Therapies, Inc. Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 40,161 shares of ITCI stock, worth $3.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,161

Previous 401,357 89.99%

Holding current value

$3.12 Million

Previous $27.8 Million 90.1%

% of portfolio

0.0%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$64.76 - $79.84 $23.4 Million - $28.8 Million	-361,196 Reduced 89.99%	40,161 $2.75 Million
Q1 2024 May 15, 2024	SELL	$64.37 - $75.65 $5.65 Million - $6.64 Million	-87,780 Reduced 17.95%	401,357 $27.8 Million
Q4 2023 Feb 14, 2024	BUY	$46.37 - $73.65 $411,023 - $652,833	8,864 Added 1.85%	489,137 $35 Million
Q3 2023 Nov 14, 2023	SELL	$52.09 - $64.1 $6.81 Million - $8.37 Million	-130,642 Reduced 21.38%	480,273 $25 Million
Q2 2023 Aug 14, 2023	SELL	$54.67 - $66.44 $8.95 Million - $10.9 Million	-163,625 Reduced 21.13%	610,915 $38.7 Million
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $21.4 Million - $27.8 Million	487,851 Added 170.17%	774,540 $41.9 Million
Q4 2022 Feb 14, 2023	BUY	$44.07 - $54.45 $2.64 Million - $3.26 Million	59,948 Added 26.44%	286,689 $15.2 Million
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $1.65 Million - $2.32 Million	38,690 Added 20.57%	226,741 $10.5 Million
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $2.63 Million - $4.01 Million	61,050 Added 48.07%	188,051 $10.7 Million
Q1 2022 May 16, 2022	SELL	$38.74 - $62.09 $808,310 - $1.3 Million	-20,865 Reduced 14.11%	127,001 $7.77 Million
Q4 2021 Feb 14, 2022	BUY	$35.2 - $53.42 $59,875 - $90,867	1,701 Added 1.16%	147,866 $7.73 Million
Q3 2021 Nov 16, 2021	BUY	$28.72 - $42.49 $404,377 - $598,259	14,080 Added 10.66%	146,165 $5.45 Million
Q2 2021 Aug 16, 2021	BUY	$29.3 - $44.5 $435,456 - $661,359	14,862 Added 12.68%	132,085 $5.39 Million
Q1 2021 May 17, 2021	BUY	$30.8 - $39.51 $2.17 Million - $2.78 Million	70,440 Added 150.57%	117,223 $3.98 Million
Q4 2020 Feb 16, 2021	BUY	$23.34 - $32.22 $1.09 Million - $1.51 Million	46,783 New	46,783 $1.49 Million
Q4 2017 Feb 09, 2018	SELL	$14.27 - $16.79 $499,450 - $587,650	-35,000 Closed	0 $0
Q2 2017 Aug 17, 2017	BUY	N/A	35,000	35,000 $435,000

Others Institutions Holding ITCI

# of Institutions

400

Shares Held

87.2M

Call Options Held

309K

Put Options Held

302K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.33B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Intra Cellular Therapies, Inc. Transaction History